About the OSU College of Pharmacy: The College of Pharmacy prepares students of today to be the pharmacy practitioners and pharmaceutical sciences researchers of tomorrow by contributing to improved health, advancing patient care and the discovery and understanding of medicines.

Oregon State researchers develop device for better delivery of gene therapy for lung disease

PORTLAND, Ore. – Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis.

Researchers closing in on genetic treatments for hereditary lung disease, vision loss

Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.

Compound derived from hops reduces abundance of gut microbe associated with metabolic syndrome

CORVALLIS, Ore. – Researchers have shown in a mouse model and lab cultures that a compound derived from hops reduces the abundance of a gut bacterium associated with metabolic syndrome.

New drug delivery system shows promise in treatment of life-threatening pregnancy condition

PORTLAND, Ore. – Researchers in the Oregon State University College of Pharmacy have developed a drug delivery system that shows promise for greatly enhancing the efficacy of the medicine given to women with the life-threatening condition of ectopic pregnancy, which occurs when a fertilized egg implants somewhere other than the lining of the uterus.

Oregon State names dean of College of Pharmacy

David Bearden, interim dean of Oregon State University’s College of Pharmacy since December 2020, has been named dean of the college.

Opioid overdose risk 10 times greater for those recently released from prison, research shows

People recently released from prison in Oregon face a risk for opioid overdose 10 times greater than the general public, according to a new study led by an Oregon State University College of Pharmacy scientist.

Two anticonvulsants prescribed for pain only ‘modestly effective’ and not without risk, study shows

PORTLAND, Oregon – A study by Oregon State University College of Pharmacy researchers suggests that two anticonvulsants often prescribed for chronic pain are only “modestly effective” at pain management and can create an unfavorable risk/reward situation for patients.

Oregon State researchers develop new, heat-efficient nanoparticles for treating cancer

PORTLAND, Ore. – Oregon State University scientists have invented a way to make magnetic nanoparticles that get hotter than any previous nanoparticle, improving their cancer fighting ability.

Oregon State researchers take key step toward improving treatment of cystic fibrosis

PORTLAND, Oregon – Researchers at Oregon State University and Oregon Health & Science University have taken a key step toward improving and lengthening the lives of cystic fibrosis patients, who experience chronically clogged airways and a dramatically shortened life expectancy.

Nanotechnology, messenger RNA combined in possible new ‘universal’ COVID-19 treatment

PORTLAND, Ore. – A study led by an Oregon State University pharmaceutical sciences researcher has produced a proof of principle for a new “universal” means of treating COVID-19.

Pages